The Med
US$ 20.76
glp-1 liver disease Current status of glucagon-like peptide-1 receptor agonists in metabolic dysfunction-associated steatotic disease: A clinical perspective GLP1s may lower 10-year risk
Description
Hims & Hers Health (NYSE:HIMS) is facing a patent infringement lawsuit from Novo Nordisk over its compounded weight loss drugs
Schedule a consultation to see if you qualify!
New data is illuminating the full profile of GLP-1 side effects
Background:Traditional risk factors associated with idiopathic intracranial hypertension (IIH) include obesity, weight gain, and female sex
PlexusDx provides personalized guidance for safe weight management with gastrointestinal history
Joel Habener have been selected as the recipients of the 2025 Distinguished Medical Science Award.